Abound Wealth Management’s ResMed RMD Stock Holding History

Abound Wealth Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$585	Sell	3 -13	-81%	-$2.69K	﹤0.01%	917
2026 Q1	$3.59K	Hold	16	–	–	﹤0.01%	800
2025 Q4	$3.86K	Hold	16	–	–	﹤0.01%	733
2025 Q3	$4.38K	Hold	16	–	–	﹤0.01%	673
2025 Q2	$4.13K	Hold	16	–	–	﹤0.01%	624
2025 Q1	$3.58K	Sell	16 -6	-27%	-$1.4K	﹤0.01%	603
2024 Q4	$5.03K	Sell	22 -4	-15%	-$963	﹤0.01%	525
2024 Q3	$6.35K	Hold	26	–	–	﹤0.01%	500
2024 Q2	$4.98K	Hold	26	–	–	﹤0.01%	501
2024 Q1	$5.15K	Hold	26	–	–	﹤0.01%	511
2023 Q4	$4.47K	Sell	26 -23	-47%	-$3.53K	﹤0.01%	535
2023 Q3	$7.25K	Buy	49 +29	+145%	+$5.24K	﹤0.01%	392
2023 Q2	$4.37K	Hold	20	–	–	﹤0.01%	518
2023 Q1	$4.38K	Buy	20 +5	+33%	+$1.08K	﹤0.01%	441
2022 Q4	$3.12K	Buy	15 +2	+15%	+$439	﹤0.01%	446
2022 Q3	$2.84K	Buy	+13	New	+$2.96K	﹤0.01%	438

Other funds holding RMD

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM

DJSG

D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Addenda Capital Montreal, Quebec, Canada $3.68B AUM 32.88% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

NAM

NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Abound Wealth Management's RMD Position: Q2 2026 in Review

Abound Wealth Management reduced its ResMed (RMD) stake by 81% in Q2 2026, selling an estimated $2.69K and leaving 3 shares worth $585. The position accounts for ﹤0.01% of the portfolio, ranked #917.

Abound Wealth Management first reported a position in RMD in Q3 2022 and has held it in 16 quarters since. The position peaked at $7.25K in Q3 2023. 139 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Abound Wealth Management held 3 shares of ResMed worth $585 as of Q2 2026.
Abound Wealth Management sold 13 ResMed shares in Q2 2026, an estimated $2.69K.
ResMed made up ﹤0.01% of Abound Wealth Management's portfolio in Q2 2026, its #917 holding.
Abound Wealth Management first reported a position in ResMed in Q3 2022 and has held it in 16 quarters since.
Abound Wealth Management's ResMed position peaked at $7.25K in Q3 2023.
139 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.